ADVERTISEMENT
ADVERTISEMENT
U.S. Senators warn of drug supply risks tied to China, India
The senators said the inquiry aims to ensure consistent access to safe and affordable medications, particularly for seniors.
-
Lalit K Jha (5WH) - Thu, 30, Oct 2025
- 02:03 EDT
- 20
Representative image / AI generated
Regulatory gaps and geopolitical tensions with China and India could threaten the safety and stability of the nation’s pharmaceutical supply chain, two senior U.S. senators said, warning of America’s growing dependence on foreign-made generic drugs.
Senate Special Committee on Ageing Chairman Rick Scott, a Republican from Florida, and Ranking Member Kirsten Gillibrand, a Democrat from New York, have sent letters to the chief executives of three major group purchasing organizations — Vizient, Premier Inc., and HealthTrust Performance Group — seeking information on vulnerabilities in sourcing foreign-manufactured medications.
This post is for paying subscribers only
SUBSCRIBE NOWRelated
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login